{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:00:09Z","timestamp":1790190009504,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>By 2030, an estimated 75% of cancer deaths will occur in low- and middle-income countries (LMICs). Weak surveillance systems and limited research infrastructure often hide the true magnitude of this burden. Thus, independent, locally led research is essential for generating high-quality data, addressing regional disease patterns, and informing context-specific strategies for cancer control. Low national investment, heavy reliance on industry-sponsored trials, and a scarcity of trained clinician scientists hinder independent cancer research in LMICs. In this narrative review, we synthesize the published literature and present a descriptive analysis of oncology trials registered on ClinicalTrials.gov (accessed July 2025), categorized by country, funding source, and tumor site and normalized to disease burden, drawing on illustrative examples from Africa, Asia, and Latin America. We highlight the transformative impact of context-sensitive research initiatives, explore disparities in sponsorship by country and tumor type, and outline ways to strengthen the research infrastructure. These include the establishment of population-based cancer registries, regional funding mechanisms, streamlined regulatory frameworks, and workforce development through formal research training and protected time. Finally, we propose strategies to enhance international collaboration and amplify LMIC participation in setting global cancer research priorities.<\/jats:p>","DOI":"10.1093\/oncolo\/oyag356","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:21:55Z","timestamp":1788780115000},"source":"Crossref","is-referenced-by-count":0,"title":["Independent cancer research in low- and middle-income countries: why it matters and how to build it"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"first","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan) Thoracic Oncology Unit, , Mexico City, 14080,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-1671","authenticated-orcid":false,"given":"Eduardo","family":"Rios-Garcia","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan) Thoracic Oncology Unit, , Mexico City, 14080,","place":["Mexico"]},{"name":"Facultad de Ciencias de la Salud, Universidad An\u00e1huac M\u00e9xico Norte Centro de Investigaci\u00f3n en Ciencias de la Salud (CICSA), , Huixquilucan, Estado de M\u00e9xico, 52786,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5982-2795","authenticated-orcid":false,"given":"Cittim B","family":"Palomares-Palomares","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan) Thoracic Oncology Unit, , Mexico City, 14080,","place":["Mexico"]},{"name":"Universidad Aut\u00f3noma de Baja California (UABC) Facultad de Ciencias Administrativas y Sociales, , Ensenada, Baja California, 22860,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aranda-Gutierrez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n Departamento de Hemato-Oncolog\u00eda, , Mexico City, 14080,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3114-0642","authenticated-orcid":false,"given":"Regina","family":"Barragan-Carrillo","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan) Medical Oncology Department, , Mexico City, 14080,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H","family":"Barrios","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Lucas PUCRS Latin American Cooperative Oncology Group (LACOG), Centro de Pesquisa em Oncologia, , Porto Alegre, 90610,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F","family":"Cardona","sequence":"additional","affiliation":[{"name":"Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC) Thoracic Oncology Unit and Direction of Research and Education, , Bogot\u00e1, 110131,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Corrales","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n y Manejo del C\u00e1ncer (CIMCA) Department of Medical Oncology, , San Jos\u00e9, 10103,","place":["Costa Rica"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjust","family":"Florez","sequence":"additional","affiliation":[{"name":"Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA 02215,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Hernandez-Martinez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan) Thoracic Oncology Unit, , Mexico City, 14080,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-7332","authenticated-orcid":false,"given":"Claudio","family":"Martin","sequence":"additional","affiliation":[{"name":"Alexander Fleming Institute Thoracic Oncology Unit, Buenos Aires, C1426,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-9010","authenticated-orcid":false,"given":"Jackson","family":"Orem","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute , Kampala, 3935,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo","family":"Pino","sequence":"additional","affiliation":[{"name":"Carlos Ardila L\u00fclle Cancer Institute-ICCAL, Fundaci\u00f3n Santa Fe de Bogot\u00e1 Clinical Oncology Department, , Bogot\u00e1, 110111,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Plancarte","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda (INCan) Pain Clinic, , Mexico City, 14080,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-105X","authenticated-orcid":false,"given":"Gustavo","family":"Werutsky","sequence":"additional","affiliation":[{"name":"Latin American Cooperative Oncology Group (LACOG) , Porto Alegre-RS, 90619,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S","family":"Pramesh","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, National Cancer Grid (India), Homi Bhabha National Institute , Mumbai, 400012,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026092314103802700_oyag356-B1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","article-title":"Priorities for cancer research in low- and Middle-income countries: a global perspective","volume":"28","author":"Pramesh","year":"2022","journal-title":"Nat Med"},{"key":"2026092314103802700_oyag356-B2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026092314103802700_oyag356-B3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12961-020-00658-x","article-title":"Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessment","volume":"19","author":"Hanna","year":"2021","journal-title":"Health Res Policy Syst"},{"key":"2026092314103802700_oyag356-B4","volume-title":"NCI Budget Fact Book for Fiscal Year 2020","author":"National Cancer Institute","year":"2021"},{"key":"2026092314103802700_oyag356-B5","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"2026092314103802700_oyag356-B6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"2026092314103802700_oyag356-B7","doi-asserted-by":"publisher","first-page":"e2400338","DOI":"10.1200\/GO-24-00338","article-title":"Real-world survival outcomes in non\u2013small cell lung cancer: the impact of genomic testing and targeted therapies in a Latin American middle-income country","volume":"10","author":"Hernandez-Martinez","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"2026092314103802700_oyag356-B8","author":"UNESCO Institute for Statistics","year":"2025"},{"key":"2026092314103802700_oyag356-B9","doi-asserted-by":"publisher","first-page":"100263","DOI":"10.1016\/j.jcpo.2020.100263","article-title":"Challenges faced by cancer patients in Uganda: implications for health systems strengthening in resource limited settings","volume":"27","author":"Nakaganda","year":"2021","journal-title":"J Cancer Policy"},{"key":"2026092314103802700_oyag356-B10","doi-asserted-by":"publisher","first-page":"JGO1900031","DOI":"10.1200\/JGO.19.00031","article-title":"The state of cancer care in Venezuela","volume":"5","author":"Duma","year":"2019","journal-title":"J Glob Oncol"},{"key":"2026092314103802700_oyag356-B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.05.033","article-title":"Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the Tenjin study)","volume":"126","author":"Ruiz-Pati\u00f1o","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"2026092314103802700_oyag356-B12","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1097\/JTO.0b013e31822f655f","article-title":"Genotyping non-small cell lung cancer (NSCLC) in Latin America","volume":"6","author":"Arrieta","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026092314103802700_oyag356-B13","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1200\/JCO.24.00843","article-title":"Patient enrollment to industry-sponsored versus federally-sponsored cancer clinical trials","volume":"42","author":"Unger","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026092314103802700_oyag356-B14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-024-08035-2","article-title":"Early versus deferred use of cdk4\/6 inhibitors in advanced breast cancer","volume":"636","author":"Sonke","year":"2024","journal-title":"Nature"},{"key":"2026092314103802700_oyag356-B15","doi-asserted-by":"publisher","first-page":"116051","DOI":"10.1016\/j.ejca.2025.116051","article-title":"Health economic outcomes and costs of cdk4\/6 inhibitor use in first- versus second-line for advanced breast cancer: a cost-effectiveness analysis of the phase 3 sonia trial","volume":"231","author":"Wortelboer","year":"2025","journal-title":"Eur J Cancer"},{"key":"2026092314103802700_oyag356-B16","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.1038\/s41467-025-59744-9","article-title":"Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-b): a single-arm, phase 2 trial","volume":"16","author":"Arrieta","year":"2025","journal-title":"Nat Commun"},{"key":"2026092314103802700_oyag356-B17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaoncol.2020.7478","article-title":"An analysis of contemporary oncology randomized clinical trials from low\/middle-income vs high-income countries","volume":"7","author":"Wells","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026092314103802700_oyag356-B18","doi-asserted-by":"publisher","first-page":"e001853","DOI":"10.1136\/bmjgh-2019-001853","article-title":"Stuck in the middle: a systematic review of authorship in collaborative health research in Africa, 2014-2016","volume":"4","author":"Hedt-Gauthier","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2026092314103802700_oyag356-B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"2026092314103802700_oyag356-B20","first-page":"37","article-title":"Biomedical research in Mexico: a perspective from the private medical sector","volume":"14","author":"Mendez-Sanchez","year":"2012","journal-title":"Medicina Universitaria"},{"key":"2026092314103802700_oyag356-B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_321335","article-title":"Is independent clinical research possible in low- and middle-income countries? A roadmap to address persistent and new barriers and challenges","volume":"41","author":"Barrios","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026092314103802700_oyag356-B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2018.02.014","article-title":"The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments","volume":"119","author":"Raez","year":"2018","journal-title":"Lung Cancer"},{"key":"2026092314103802700_oyag356-B23","doi-asserted-by":"publisher","first-page":"1601483","DOI":"10.3389\/fpubh.2025.1601483","article-title":"Cancer survivorship in low- and middle-income countries: challenges, needs, and emerging support strategies","volume":"13","author":"Dos Anjos","year":"2025","journal-title":"Front Public Health"},{"key":"2026092314103802700_oyag356-B24","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/S1470-2045(25)00039-7","article-title":"National cancer control plans in Latin America and the Caribbean: challenges and future directions","volume":"26","author":"Villarreal-Garza","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026092314103802700_oyag356-B25","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","article-title":"Cancer registration in China and its role in cancer prevention and control","volume":"21","author":"Wei","year":"2020","journal-title":"Lancet Oncol"},{"key":"2026092314103802700_oyag356-B26","doi-asserted-by":"publisher","first-page":"100671","DOI":"10.1016\/j.lana.2023.100671","article-title":"Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group","volume":"30","author":"Pestana","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"2026092314103802700_oyag356-B27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.cllc.2022.06.001","article-title":"Mechanisms of resistance to first-line osimertinib in Hispanic patients with EGFR mutant non-small cell lung cancer (freston-clicap)","volume":"23","author":"Cardona","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"2026092314103802700_oyag356-B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2023-112490","article-title":"Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India","author":"Ghosh","year":"2025","journal-title":"BMJ Evid Based Med"},{"key":"2026092314103802700_oyag356-B29","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S1470-2045(21)00720-8","article-title":"Cancer in Sub-Saharan Africa: a lancet oncology commission","volume":"23","author":"Ngwa","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026092314103802700_oyag356-B30","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.7011","article-title":"Breast cancer diagnostics, therapy, and outcomes in Sub-Saharan Africa: a population-based registry study","volume":"20","author":"Joko-Fru","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"2026092314103802700_oyag356-B31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med"},{"key":"2026092314103802700_oyag356-B32","doi-asserted-by":"publisher","first-page":"LBA8671","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA8671","article-title":"Pragmatica-lung (swog s2302): a prospective, randomized study of ramucirumab plus pembrolizumab versus standard of care for participants previously treated with immunotherapy for stage iv or recurrent non-small cell lung cancer","volume":"43","author":"Dragnev","year":"2025","journal-title":"J Clin Oncol"},{"key":"2026092314103802700_oyag356-B33","doi-asserted-by":"publisher","first-page":"n256","DOI":"10.1136\/bmj.n256","article-title":"Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai","volume":"372","author":"Mittra","year":"2021","journal-title":"BMJ"},{"key":"2026092314103802700_oyag356-B34","doi-asserted-by":"publisher","first-page":"e1213","DOI":"10.1016\/S2214-109X(20)30275-8","article-title":"Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial","volume":"8","author":"Patil","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026092314103802700_oyag356-B35","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1200\/JCO-24-02347","article-title":"De-escalation strategies with immune checkpoint blockers in non-small cell lung cancer: Do we already have enough evidence?","volume":"43","author":"Remon","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag356\/70984370\/oyag356.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/10\/oyag356\/70984370\/oyag356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/10\/oyag356\/70984370\/oyag356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:10:42Z","timestamp":1790187042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag356\/8787393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag356","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,7]]},"article-number":"oyag356"}}